Literature DB >> 2415368

Opioid control of the function of primary afferent substance P fibres.

F Lembeck, J Donnerer.   

Abstract

Lofentanil, a very potent and long-acting opiate agonist, was used to evaluate the opioid control of substance P release from primary afferents. Substance P release from the central terminals of primary afferents was studied in the superfused isolated dorsal half of the rat spinal cord. Substance P release as initiated by electrical field stimulation and by capsaicin was found to be diminished by 50% by lofentanil (1 microM) in a naloxone-reversible manner. Substance P release from peripheral terminals of primary afferents was induced by antidromic saphenous nerve stimulation. Release was measured indirectly by its effect on blood flow and plasma extravasation in the rat hind paw. Both antidromic vasodilatation and plasma extravasation were dose dependently inhibited by lofentanil. The inhibition of antidromic vasodilatation by 10 micrograms X kg-1 lofentanil i.p. was completely prevented by 1 mg X kg-1 naloxone. On the other hand, vasodilatation and plasma extravasation induced by infusion of 3.7 pmol X min-1 substance P remained unaffected by lofentanil. It is concluded that lofentanil inhibits the release of substance P from central as well as peripheral terminals of substance P-containing primary afferent neurons.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415368     DOI: 10.1016/0014-2999(85)90365-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  23 in total

1.  Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation.

Authors:  C Stein; A H Hassan; R Przewłocki; C Gramsch; K Peter; A Herz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  Effects of nociceptin and nocistatin on antidromic vasodilatation in hairless skin of the rat hindlimb in vivo.

Authors:  H Häbler; L Timmermann; J Stegmann; W Jänig
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

3.  Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.

Authors:  I Bileviciute-Ljungar; M Spetea
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 4.  Neuropeptides, inflammation, and motility.

Authors:  E A Mayer; H Raybould; C Koelbel
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

5.  Effect of chronic sciatic nerve lesion on the neurogenic inflammatory response in intact and acutely injured denervated rat skin.

Authors:  M Bassirat; R D Helme; Z Khalil
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

6.  Opioid modulation of non-cholinergic neural bronchoconstriction in guinea-pig in vivo.

Authors:  M G Belvisi; K F Chung; D M Jackson; P J Barnes
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

7.  Intrathecal CGRP8-37-induced bilateral increase in hindpaw withdrawal latency in rats with unilateral inflammation.

Authors:  L C Yu; P Hansson; G Brodda-Jansen; E Theodorsson; T Lundeberg
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

8.  Local opioid-sensitive afferent sensory neurones in the modulation of gastric damage induced by Paf.

Authors:  J V Esplugues; B J Whittle; S Moncada
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

9.  Peripheral effects of opioid drugs on capsaicin-sensitive neurones of the guinea-pig bronchus and rabbit ear.

Authors:  L Barthó; R Amann; A Saria; J Szolcsányi; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

10.  The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.

Authors:  J L Wilson; V Nayanar; J S Walker
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.